Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/24003
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBartley, Angela N
dc.contributor.authorWashington, Mary Kay
dc.contributor.authorVentura, Christina B
dc.contributor.authorIsmaila, Nofisat
dc.contributor.authorColasacco, Carol
dc.contributor.authorBenson, Al B
dc.contributor.authorCarrato, Alfredo
dc.contributor.authorGulley, Margaret L
dc.contributor.authorJain, Dhanpat
dc.contributor.authorKakar, Sanjay
dc.contributor.authorMackay, Helen J
dc.contributor.authorStreutker, Catherine
dc.contributor.authorTang, Laura
dc.contributor.authorTroxell, Megan
dc.contributor.authorAjani, Jaffer A
dc.date.accessioned2019-06-28T14:03:42Z-
dc.date.available2019-06-28T14:03:42Z-
dc.date.issued2016-12
dc.identifier.citationAm. J. Clin. Pathol..2016 Dec;(146)6:647-669
dc.identifier.urihttps://hdl.handle.net/20.500.12530/24003-
dc.description.abstractERBB2 (erb-b2 receptor tyrosine kinase 2 or HER2) is currently the only biomarker established for selection of a specific therapy for patients with advanced gastroesophageal adenocarcinoma (GEA). However, there are no comprehensive guidelines for the assessment of HER2 in patients with GEA.
dc.language.isoeng
dc.rightsopenAccess-
dc.subjectGastroesophageal adenocarcinoma
dc.subjectGuidelines
dc.subjectHER2 testing
dc.subject.meshAdenocarcinoma
dc.subject.meshAntineoplastic Agents
dc.subject.meshEsophageal Neoplasms
dc.subject.meshEsophagogastric Junction
dc.subject.meshGenetic Testing
dc.subject.meshHumans
dc.subject.meshMedical Oncology
dc.subject.meshReceptor, ErbB-2
dc.subject.meshStomach Neoplasms
dc.subject.meshUnited States
dc.subject.meshClinical Decision-Making
dc.titleHER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
dc.typeArtículo
dc.identifier.pubmedID28077399
dc.format.volume146
dc.format.page647-669
dc.identifier.e-issn1943-7722
dc.identifier.journalAmerican journal of clinical pathology
dc.identifier.doi10.1093/ajcp/aqw206
dc.format.number6
dc.identifier.pmcPMC6272805
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.pubmedtypeReview
dc.pubmedtypeSystematic Review
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC6272805.pdf1.46 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.